Plain-English translation of NCT05418556 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a shorter course of blood-thinning medication after heart stent placement works as well as the standard longer course. After your stent is placed using special imaging to ensure it's positioned perfectly, you'll be randomly assigned to either take blood thinners for 12 months (the standard approach) or for a shorter period followed by a single blood thinner alone.
Long-term blood-thinning medication can increase the risk of bleeding, so doctors want to know if shorter treatment periods—especially tailored to whether you had a heart attack or stable chest pain—can reduce bleeding risk while keeping your stent working safely.
You likely qualify if…
You likely don't qualify if…
After your stent is placed, you'll be randomly assigned to one of two treatment groups. One group takes two blood-thinning medications for the full 12 months; the other group takes two medications for 1–3 months (depending on your diagnosis) and then switches to one medication alone for the remainder of the year. You'll have clinic visits at 1 month, 6 months, and 12 months after your procedure to check on your health and any side effects.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea